The expression of BTG1 is downregulated in NSCLC and possibly associated with tumor metastasis

Tumor Biology

Volumn 35, Issue 4, 2014, Pages 2949-2957

  Sun, G G ^a   Lu, Y F ^b   Cheng, Y J ^c   Hu, W N ^a  

^a TANGSHAN PEOPLE S HOSPITAL   (China)

^b Tangshan Worker's Hospital   (China)

^c HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Bcl 2; BTG1; CyclinD1; Metastasis; MMP 9; NSCLC

Indexed keywords

CYCLIN D1; GELATINASE B; LENTIVIRUS VECTOR; MESSENGER RNA; PROTEIN BCL 2;

ADULT; APOPTOSIS; ARTICLE; B CELL TRANSLOCATION GENE 1; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MTT ASSAY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROGNOSIS;

EID: 84898864159     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1379-6     Document Type: Article

References (20)

1. Okuyama T, Maehara Y, Kabashima A, Takahashi I, Kakeji Y, Sugimachi K. Combined evaluation of expressions of p53 and p21 proteins as prognostic factors for patients with gastric carcinoma. Oncology. 2002;63:353-61.
2. Cortes U, Moyret-Lalle C, Falette N, Duriez C, Ghissassi FE, Barnas C, et al. BTG gene expression in the p53-dependent and -independent cellular response to DNA damage. Mol Carcinog. 2000;27:57-64.
3. Winkler GS. The mammalian anti-proliferative BTG/Tob protein family. J Cell Physiol. 2010;222:66-72.
4. Rouault JP, Rimokh R, Tessa C, Paranhos G, Ffrench M, Duret L, et al. BTG1, a member of a new family of antiproliferative genes. EMBO J. 1992;11:1663-70.
5. Matsuda S, Rouault J, Magaud J, Berthet C. In search of a function for the TIS21/PC3/BTG1/TOB family. FEBS Lett. 2001;497:67-72.
6. Rouault JP, Falette N, Guéhenneux F, Guillot C, Rimokh R, Wang Q, et al. Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular responsepathway. Nat Genet. 1996;14:482-6.
7. Zhu R, Zou ST, Wan JM, Li W, Li XL, Zhu W. BTG1 inhibits breast cancer cell growth through induction of cell cycle arrest and apoptosis. Oncol Rep. 2013;30:2137-44.
8. Pramesh CS, Mistry RC, Jambhekar NA, Laskar SG. Does the TNM staging system for esophageal cancer need revision? J Am Coll Surg. 2006;202:855-6.
9. Martinez-Outschoorn UE, Pavlides S, Sotgia F, Lisanti MP. Mitochondrial biogenesis drives tumor cell proliferation. Am J Pathol. 2011;178:1949-52.
10. Koff A, Cross F, Fisher A, Schumacher J, Leguellec K, Philippe M, et al. Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell. 1991;66:1217-28.
11. Kwon TK, Nordin AA. Overexpression of cyclin E and cyclin dependent kinase inhibitor p27kip1: effect on cell cycle regulation in Hela cell. Biochem Biophys Res Commun. 1997;238:534-8.
12. Nicholson DW, Thornberry NA. Apoptosis. Life and death decisions. Science. 2003;299:214-5.
13. Tirone F. The gene PC3(TIS21/BTG2), prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair? J Cell Physiol. 2001;187:155-65.
14. Corjay MH, Kearney MA, Munzer DA, Diamond SM, Stoltenborg JK. Antiproliferative gene BTG1 is highly expressed in apoptotic cells in macrophage-rich areas of advanced lesions in Watanabe heritable hyperlipidemic rabbit and human. Lab Invest. 1998;78:847-58.
15. Lee H, Cha S, Lee MS, Cho GJ, Choi WS, Suk K. Role of antiproliferative B cell translocation gene-1 as an apoptotic sensitizer in activation-induced cell death of brain microglia. J Immunol. 2003;171:5802-11.
16. Nahta R, Yuan LX, Fiterman DJ, Zhang L, Symmans WF, Ueno NT, et al. B cell translocation gene 1 contributes to antisense Bcl-2-mediated apoptosis in breast cancer cells. Mol Cancer Ther. 2006;5:1593-601.
17. Ermiah E, Buhmeida A, Khaled BR, Abdalla F, Salem N, Pyrhönen S, et al. Prognostic value of bcl-2 expression among women with breast cancer in Libya. Tumour Biol. 2013;34:1569-1578.
18. Gu Y, Pan Y, Meng B, Guan B, Fu K, Sun B, et al. High levels of bcl-2 protein expression do not correlate with genetic abnormalities but predict worse prognosis in patients with lymphoblastic lymphoma. Tumour Biol. 2013;34:1441-1450.
19. Wiseman BS, Werb Z. Stromal effects on mammary gland development and breast cancer. Science. 2002;296:1046-9.
20. Alok C, Bharat B. Nuclear factor-kappa B and cancer: its role in prevention and therapy. Biochem Phamacol. 2002;64:883-8.